The term “Genetron” is derived from Darwin's "pangenesis theory", the original definition of human genetic material—genes.
Genetron Health (Nasdaq:GTH) is a leading precision oncology platform company in China that specializes in cancer molecular profiling and harnesses advanced technologies in molecular biology and data science to transform cancer treatment. The Company has developed a comprehensive oncology portfolio that covers the entire spectrum of cancer management, addressing needs and challenges from early screening, diagnosis and treatment recommendations, continuous disease monitoring and care, as wells as biopharma development services. Genetron Health offers customized services and products. The ultimate goal is to defeat cancer.
DIVERSIFIED SOLUTIONS COVERING THE FULL-CYCLE OF CANCER MANAGEMENT
DIAGNOSTICS & MONITORING
BIOPHARMA DEVELOPMENT SERVICES
Genetron Health Brand Values
Our team of scientists has deep experience in cancer genomics research and clinical translational research, having published dozens of papers in leading international academic journals. The research fields we cover include lung cancer, digestive tract cancer, thyroid cancer and cancers of the central nervous system. Genetron Health has established long-term partnerships with Duke University and Johns Hopkins University. Genetron Health’s innovative One-Step Seq Method and Mutation Capsule have proven to be of significant value for the clinical management of cancer.
Genetron Health's product and service solutions span the fields of early cancer screening, diagnosis and monitoring, biopharma services. Covering top ten major cancer types in China. Our products are capable of detecting multiple tissue and liquid sample forms. The two forms of "LDT testing service + IVD instrument reagent" focused on clinical appeals, have reliable service and product quality assurance. We have also been involved in writing a number of industry standards, and we are committed to providing solutions for healthy and high-risk groups, patients, doctors, and pharmaceutical companies.
Genetron Health takes advantage of global R&D resources. We focus on the Chinese market, but partner with global companies such as Illumina, Thermo Fisher, BGI, Roche, AstraZeneca, InnoCare, and CStone Pharmaceuticals. With our own global resources, we are committed to providing more people with products and services that cover the full cancer cycle.
Adhering to the mission of “Defeat Cancer and Protect Life”, Genetron Health is committed to becoming an excellent corporate citizen and protecting public health. We do this by focusing on users and providing users with products and services throughout the full cancer cycle. We do this by focusing on our employees, paying attention to their growth, by emphasizing equality and inclusiveness, by providing career opportunities through R & D and management, and by helping employees to achieve their dreams and ideals. We do this by focusing on the public and promoting the social awareness of the significance of precision medicine to health through public welfare such as health science popularization and community service.